Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide with Closed Loop Insulin in T1D
NCT01755416Phase 2Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Jan 2013
- Primary completion
- Jan 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in type 1 diabetes mellitus (T1D), sponsored by Albert Einstein College of Medicine. Started Jan 2013; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01755416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755416.